BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4106604)

  • 1. Prednisone side-effects and serum-protein levels. A collaborative study.
    Lewis GP; Jusko WJ; Graves L; Burke CW
    Lancet; 1971 Oct; 2(7728):778-80. PubMed ID: 4106604
    [No Abstract]   [Full Text] [Related]  

  • 2. Prednisolone binding to albumin and transcortin in the presence of cortisol.
    Rocci ML; D'Ambrosio R; Johnson NF; Jusko WJ
    Biochem Pharmacol; 1982 Feb; 31(3):289-92. PubMed ID: 7073761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.
    Frey BM; Schaad HJ; Frey FJ
    Eur J Clin Pharmacol; 1984; 26(4):505-11. PubMed ID: 6734709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Representation and quantitation of the binding interaction between prednisone, prednisolone and corticosteroid binding globulin.
    Unadkat JD; Rowland M
    J Pharm Pharmacol; 1984 Sep; 36(9):582-5. PubMed ID: 6149280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered prednisolone kinetics in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Nephron; 1982; 32(1):45-8. PubMed ID: 7177276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of prednisolone to alpha 1-acid glycoprotein.
    Milsap RL; Jusko WJ
    J Steroid Biochem; 1983 Feb; 18(2):191-4. PubMed ID: 6843123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man.
    Angeli A; Frajria R; De Paoli R; Fonzo D; Ceresa F
    Clin Pharmacol Ther; 1978 Jan; 23(1):47-53. PubMed ID: 563315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW; Axelsen E
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion.
    Frey BM; Frey FJ
    Br J Clin Pharmacol; 1982 Feb; 13(2):245-9. PubMed ID: 6800390
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.
    Gatti G; Perucca E; Frigo GM; Notarangelo LD; Barberis L; Martini A
    Br J Clin Pharmacol; 1984 Apr; 17(4):423-31. PubMed ID: 6721988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of a synthetic progestin, R5020 to transcortin and serum albumin.
    Chan DW; Slaunwhite WR
    J Clin Endocrinol Metab; 1977 May; 44(5):983-5. PubMed ID: 858781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein binding interaction of prednisone and prednisolone.
    Boudinot FD; Jusko WJ
    J Steroid Biochem; 1984 Sep; 21(3):337-9. PubMed ID: 6492791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding characteristics of transcortin, thyroxine binding globulin and pre-albumin in Jamaicans.
    Keane PM; Pegg PJ; Johnson E; Adam M
    West Indian Med J; 1971 Dec; 20(4):271-5. PubMed ID: 5006233
    [No Abstract]   [Full Text] [Related]  

  • 15. The nonlinear pharmacokinetics of prednisone and prednisolone. II. Plasma protein binding of prednisone and prednisolone in rabbit and human plasma.
    Ferry JJ; Wagner JG
    Biopharm Drug Dispos; 1987; 8(3):261-72. PubMed ID: 3593903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of three constants involved in the binding of corticosterone to plasma proteins in the rat.
    Jobin M; Perrin F
    Can J Biochem; 1974 Feb; 52(2):101-5. PubMed ID: 4819803
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.
    Wagner JG; Wexler D; Ağabeyoğlu IT; Bergstrom RF; Sakmar E; Kay DR
    J Lab Clin Med; 1981 Apr; 97(4):487-501. PubMed ID: 7205057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transplacental passage of prednisone and prednisolone in pregnancy near term.
    Beitins IZ; Bayard F; Ances IG; Kowarski A; Migeon CJ
    J Pediatr; 1972 Nov; 81(5):936-45. PubMed ID: 5086721
    [No Abstract]   [Full Text] [Related]  

  • 19. Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects.
    Uribe M; Go VL; Kluge D
    J Clin Gastroenterol; 1984 Aug; 6(4):331-5. PubMed ID: 6481116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol binding capacity in plasma during anaesthesia and surgery.
    Kehlet H; Binder C; Engbaek C
    Acta Endocrinol (Copenh); 1974 Jan; 75(1):119-24. PubMed ID: 4406475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.